TTC25 Activators
Forskolin and cAMP analogs like Calcium dibutyryladenosine cyclophosphate raise the levels of cAMP, a secondary messenger that activates PKA. The phosphorylation events following PKA activation can affect numerous proteins and pathways, including those associated with TTC25. Similarly, small molecule inhibitors like PD98059, LY294002, SB203580, and Rapamycin target key kinases and phosphatases within signal transduction pathways. By modulating the activity of these enzymes, these chemicals can alter the phosphorylation state of a range of proteins, potentially including TTC25 or its associated partners. Additionally, changes in gene expression orchestrated by Retinoic Acid or Sodium Butyrate, through their influence on nuclear receptors and chromatin accessibility, respectively, could result in altered levels of TTC25 or modify its regulatory landscape.
Calcium ionophores like Ionomycin directly alter intracellular calcium concentrations, a critical second messenger influencing numerous calcium-dependent signaling processes. The perturbation of calcium signaling can lead to modifications in the activity of proteins that are part of, or interact with, TTC25-dependent pathways. Furthermore, the provision of essential ions such as zinc by Zinc Sulfate can stabilize protein structures and enhance the catalytic activity of metalloenzymes, which may impact the biological function of TTC25.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Affects numerous signaling pathways that may intersect with TTC25's regulatory mechanisms. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulates gene expression by acting on nuclear receptors, influencing transcription of genes including those associated with TTC25. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
A cAMP analog that directly activates PKA, potentially affecting proteins and pathways interacting with TTC25. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can modulate signaling pathways in which TTC25 is involved. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, altering calcium-dependent signaling pathways that TTC25 may be part of. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that can alter MAPK/ERK pathway signaling, potentially affecting TTC25's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can modulate the AKT signaling pathway, which may intersect with TTC25 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that might affect pathways involving TTC25. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, which can influence pathways interconnected with TTC25. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can change chromatin architecture and gene expression profiles, including those related to TTC25. | ||||||